RXDX News and Press, Prometheus Biosciences Inc. From 05/01/23

2023-05-01 13:29:00 ET Abbvie ( ABBV ) and Bristol-Myers Squibb ( BMY ) competed to takeover Prometheus Biosciences ( NASDAQ: RXDX ), before Merck ( NYSE: MRK ) won in its pursuit of the biotech company. The interest from other unidentified suitors for Prometheus...

2023-04-27 09:15:00 ET There's nothing quite like a big acquisition to turn a business around. Consider how CVS Health acquired health insurer Aetna to broaden its operations; AbbVie acquired Botox-maker Allergan, which also helped diversify its business; and most recently, Pfizer...

NEW YORK, NY / ACCESSWIRE / April 27, 2023 / New York, New York-Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: TESSCO Technologi...

NEW YORK, NY / ACCESSWIRE / April 25, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Prometheus Biosciences, Inc. (NASDAQ...

2023-04-24 05:31:06 ET Summary Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity. Biotech deal-making has been increasing, with large acquisitions such as Pfizer's acquisit...

2023-04-23 12:00:00 ET Biotech deal-making is on a roll, with more than $12B worth of transactions announced over the past week alone, and, according to industry observers, the trend is expected to continue in 2023, supported by macro and certain industry-specific factors. Days after Me...

2023-04-21 16:28:07 ET Summary Merck & Co., Inc. has reached a near $11 billion deal to acquire Prometheus Biosciences, Inc. The deal adds to the pipeline, badly needed as Keytruda reliance is high and growing. The transaction comes after Pfizer acquired Merck's former tar...

NEW YORK, NY / ACCESSWIRE / April 21, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Prometheus Biosciences, Inc. (NASDAQ:RX...

2023-04-21 11:13:41 ET Summary We believe the M&A wave in the biotech sector presents a prime opportunity for investors to profit from the rising valuations of small and mid-cap firms in SPDR® S&P Biotech ETF. Big pharma companies, facing patent cliffs and pricing pre...

2023-04-20 16:24:00 ET Shares of Prometheus Biosciences (NASDAQ: RXDX) were skyrocketing 70% higher this week, as of the market close on Thursday, according to data provided by S&P Global Market Intelligence . The huge gain came after Merck (NYSE: MRK) annou...